Patents by Inventor Kelly P. Longo

Kelly P. Longo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biaryl compounds useful as anticancer agents
    Patent number: 6576632
    Abstract: The present invention relates to compounds of formula I and to pharmaceutically acceptable salts, hydrates and prodrugs thereof, wherein R1, R2, R3, R4, R5, R10, R11, b, m, n, p and v are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and methods of treating hyperproliferative disorders in mammals by administering the above compounds.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: June 10, 2003
    Assignee: Pfizer Inc
    Inventors: Steven W. Goldstein, Kelly P. Longo, James F. Blake, Mohamed M. A. Awad, Kenneth P. Raiche, Kevin W. Kramer
  • Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
    Patent number: 6541495
    Abstract: A method of treating hyperproliferation diseases in mammals in need of such treatment, which method includes administering to said mammal a therapeutically effective amount of a compound of the formula: or a pharmaceutically acceptable salt, hydrate or prodrug thereof, wherein R1, R2, R3, R4, W, X, Y, Z and t are as defined herein.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: April 1, 2003
    Assignee: Pfizer INC
    Inventors: Steven W. Goldstein, Kelly P. Longo, Bernard Hulin
  • Benzazepine derivatives as inhibitors of hyperproliferation diseases
    Patent number: 6319915
    Abstract: A method of treating hyperproliferation diseases in mammals in need of such treatment which method includes administering to said mammal a therapeutically effective amount of a compound of the formula: or a pharmaceutically acceptable salt, hydrate or prodrug thereof, wherein R1, R2, R3, R4, W, X, Y, Z and t are as defined herein.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: November 20, 2001
    Assignee: Pfizer Inc.
    Inventors: Steven W. Goldstein, Kelly P. Longo, Arthur A. Nagel, John A. Lowe, III